Another SEER analysis describes earlier stage disease translating to better cancer mortality for screening- versus clinically-detected ER+HER2- breast cancers in women over 70, which seems more relevant than ever in the era of partial breast irradiation and omission of chemo and sentinel node sampling. | Huang, JAMA Netw Open 2025

